Replacing ReLU with Swish offers a cost-effective, architecture-preserving strategy to improve segmentation reliability and boundary delineation and is a promising, preliminary step towards more reliable automated tumour delineation.
Abstract
Precise brain tumour delineation is vital for therapy protocols and tracking. However, standard Rectified Linear Units (ReLU) struggle to capture subtle necrotic-core variations due to zero-gradient behaviour in the negative domain. To address this, we present a controlled benchmark of 12 activation functions within a fixed Residual 3D U-Net using the Brain Tumour Segmentation (BraTS) 2020 dataset. In the single-run benchmark, Swish achieved the best necrotic-core (NCR) Dice (0.676; +2.0% over ReLU, p < 0.01), while TanhExp attained the highest whole-tumour accuracy (0.879). To test the reliability of these single-run results, the four functions central to our claims were retrained across three random seeds. This analysis confirmed a small but consistent NCR advantage for the smooth and adaptive functions—Swish (0.677 ± 0.003) and PReLU (0.678 ± 0.004) over ReLU (0.661 ± 0.012; pooled p < 0.001)—with Swish among the most stable functions in this region. By contrast, the apparent single-run differences in the enhancing tumour, and the underperformance of PReLU, did not generalise across seeds, indicating that activation-function effects in this task are concentrated in the necrotic core and that single-seed comparisons can be misleading. Crucially, Swish achieved these gains with zero additional trainable parameters and only a ~1% training latency penalty on common hardware. Replacing ReLU with Swish offers a cost-effective, architecture-preserving strategy to improve segmentation reliability and boundary delineation. Ultimately, this zero-cost architectural modification is a promising, preliminary step towards more reliable automated tumour delineation, pending prospective validation on multi-institutional data and expert radiological assessment.
A 3D U-Net-based segmentation framework, NeuroFocusNet, which synchronizes spatial attention, channel recalibration, and attention-gated skip connections within a single volumetric encoder-decoder model is proposed, which is encouraging when considering the feasibility of using NeuroFocusNet as a technically promising...
Faizan Ullah, Z. Abbas, Sergo Gegechkori et al.· IEEE Access· 0 citations
Brain metastases are the most common intracranial malignancy, occurring in roughly 30% of patients with primary solid tumors and carrying a median survival near 5.9 months. Automated segmentation is critical for treatment planning and volumetric monitoring, but metastases are frequently small, numerous, and heterogeneo...
Automated prostate cancer (PCa) lesion segmentation using deep learning remains constrained by limited tissue contrast in standard diffusion-based MRI sequences, with state-of-the-art methods reporting Dice scores of 32% or lower on large patient cohorts. Synthetic correlated diffusion imaging (CDIs) offers a promising...
Jarett Dewbury, Chi-en Amy Tai, Alexander Wong· Signals· 0 citations
Abstract This study proposes a 2.5D input framework for brain tumor segmentation in multi-sequence magnetic resonance imaging (MRI), aiming to balance computational efficiency and spatial context compared to conventional 2D approaches. While 2D methods are efficient but limited in capturing inter-slice information, the...
Sawehel Tlahig, Max Bindemann, T. Schanze· Current Directions in Biomed...· 0 citations
Reliable delineation of tumor boundaries in magnetic resonance imaging (MRI) is a prerequisite for surgical planning and treatment monitoring, yet conventional convolutional networks remain sensitive to the orientation and positional variability inherent to clinical acquisitions. We propose a segmentation network built...
C. Angelina, Fu-Ren Xiao, Sunil Vyas et al.· Optics and Photonics Interna...· 0 citations
MMA-UNet, a novel hybrid architecture that integrates multiple complementary mechanisms within an encoder-decoder framework, demonstrates strong robustness on T1-weighted contrast-enhanced MRI, and its generalizability to larger datasets remains to be established.